12:45 IST
BSE
Earnings Call
Nath Bio-Genes (India) Investor Presentation: Key Takeaways
Nath Bio-Genes reported strong Q1 FY27 results with Revenue and EBITDA growing 15% and 17% YoY respectively. The company continues to focus on high-yield cotton, maize, and paddy seeds.